The Compare-Acute trial of fractional flow reserve-guided multivessel angioplasty in myocardial infarction

EuroIntervention 2017;13:e613-e616 published online e-edition August 2017. DOI: 10.4244/EIJV13I5A96

Chee Tang Chin
Chee Tang Chin1,2*, MBChB; Philippe L’Allier3, MD; Franz-Josef Neumann4, MD; Thomas Engstrøm5, DMSci, PhD; Peter Jüni6, MD; Goran K. Olivecrona7, MD, PhD
1. National Heart Centre Singapore, Singapore; 2. Duke-NUS Graduate Medical School, Singapore, Singapore; 3. Montreal Heart Institute, Montreal, Canada; 4. Heart Center, University of Freiburg, Freiburg, Germany; 5. Rigshospitalet, University of Copenhage

Introduction to the session: the trial headlines

The aim of the article is to capture the session at EuroPCR 2017 covering the Compare-Acute trial, communicate the analysis of the trialists, and report the views expressed in the interactive discussion. This article does not constitute an independent review of the topic by the authors.

The objective of the “Will this trial change my practice?” session was to discuss the Compare-Acute randomised trial and the extent to which it would probably change clinical practice1. The trial headlines were outlined succinctly by P.L. L’Allier. Among patients with ST-segment elevation ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Coronary interventionsSTEMIInvasive imaging and functional assessment
Read next article
The SURTAVI study: TAVI for patients with intermediate risk

Latest news